Managers / Q1 2026
Watchtower Advisors, LP
CIK 0001807092 · 1700 EAST PUTNAM AVENUE, SUITE 209, OLD GREENWICH, CT, 06870 · 203-413-8793
Summary
Watchtower Advisors, LP reported $141M in U.S.-listed holdings across 12 positions for Q1 2026.
The portfolio is heavily concentrated: Asml Holding alone accounts for 29.3% of reported value.
Compared with Q4 2025, the fund opened 3 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 53.9% · $76M
- Other · 29.3% · $41M
- REIT · 16.8% · $24M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MUMICRON TECHNOOLOGY INC | NEW | +23.0K | 23.0K | +$8M | $8M |
| ELANELANCO ANIMAL HEALTH INC | NEW | +147.8K | 147.8K | +$4M | $4M |
| SRESEMPRA | NEW | +35.7K | 35.7K | +$3M | $3M |
| ROYAL CARIBBEAN GROUP | SOLD OUT | −40.0K | 0 | −$11M | $0 |
| AZOAUTOZONE INC | SOLD OUT | −2.1K | 0 | −$7M | $0 |
| APHAMPHENOL CORP | TRIMMED | −92.6K | 7.4K | −$13M | $932,210 |
| AVGOBROADCOM INC | TRIMMED | −18.8K | 11.2K | −$7M | $3M |
| OMEGA HEALTHCARE INVS INC | ADDED | +202.0K | 541.1K | +$9M | $24M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ASML HOLDING NV | NY REGISTRY SHS | 29.29% | $41M | 31.3K |
| 2 | OMEGA HEALTHCARE INVS INC | COM | 16.82% | $24M | 541.1K |
| 3 | PATKPATRICK INDS INChistory → | COM | 11.82% | $17M | 150.0K |
| 4 | CVSCVS HEALTH CORPhistory → | COM | 9.29% | $13M | 182.4K |
| 5 | TPDSOMNIGROUP INTERNATIONAL INChistory → | COM | 7.33% | $10M | 139.9K |
| 6 | IBPINSTALLED BLDG PRODS INChistory → | COM | 6.07% | $9M | 32.3K |
| 7 | AMDADVANCED MICRO DEVICES INChistory → | COM | 5.77% | $8M | 40.0K |
| 8 | MUMICRON TECHNOOLOGY INChistory → | COM | 5.52% | $8M | 23.0K |
| 9 | ELANELANCO ANIMAL HEALTH INChistory → | COM | 2.51% | $4M | 147.8K |
| 10 | AVGOBROADCOM INChistory → | COM | 2.47% | $3M | 11.2K |
| 11 | SRESEMPRAhistory → | COM | 2.46% | $3M | 35.7K |
| 12 | APHAMPHENOL CORP | CL A | 0.66% | $932,210 | 7.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $141M | 12 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $166M | 11 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $214M | 16 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $169M | 18 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $138M | 15 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $177M | 14 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $216M | 15 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $155M | 11 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $180M | 13 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $149M | 13 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $101M | 8 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $186M | 13 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $154M | 13 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $169M | 14 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $129M | 9 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $147M | 10 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $200M | 14 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $155M | 18 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.